Ultimately, large multicenter studies confirmed that heterozygous GBA1 mutations is a genetic risk factor for both Parkinson disease (PD) and dementia with Lewy bodies (DLB), increasing the disease risk 5–10-fold, depending on the specific mutation [14,15]. This evidence concerns the gene GBA1 and Lewy body dementia.